MeMed Diagnostics Company
"Diagnostic Tools for Infectious Diseases."
MeMed Diagnostics has developed and validated an immune-based protein signature called MeMed BV for distinguishing between bacterial and viral infections, a powerful tool in the fight against resistant strains of bacteria.
An ELISA format of MeMed BV called ImmunoXpert is cleared for use in the EU (CE-IVD), Switzerland, and Israel and is currently in pilot distribution in these areas.
MeMed is also developing MeMed Key, a platform that paves the way for measuring multiple proteins and signatures, both conventional and innovative, with central lab precision at the point of care. MeMed Key will measure MeMed BV within minutes.
Combating Coronavirus Pandemic:
MeMed Diagnostics's solution helps address the Coronavirus Pandemic. MeMed Diagnostics built a diagnostic tool for distinguishing between bacterial and viral infections like the coronavirus. The company is now also developing a diagnostics test for early detection of viruses and the prediction of potential patient deterioration.
MeMed Diagnostics has developed and validated an immune-based protein signature called MeMed BV for distinguishing between bacterial and viral infections, a powerful tool in the fight against resistant strains of bacteria.
An ELISA format of MeMed BV called ImmunoXpert is cleared for use in the EU (CE-IVD), Switzerland, and Israel and is currently in pilot distribution in these areas.
MeMed is also developing MeMed Key, a platform that paves the way for measuring multiple proteins and signatures, both conventional and innovative, with central lab precision at the point of care. MeMed Key will measure MeMed BV within minutes.
Combating Coronavirus Pandemic:
MeMed Diagnostics's solution helps address the Coronavirus Pandemic. MeMed Diagnostics built a diagnostic tool for distinguishing between bacterial and viral infections like the coronavirus. The company is now also developing a diagnostics test for early detection of viruses and the prediction of potential patient deterioration.
Technology:
COVID Treatments
Industry:
Test Kits
Headquarters:
Israel
Founded Date:
2009
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership